Psychologists are concerned with a wide variety of problems

Psychologists are concerned with a wide variety of problems забавное

psychologists are concerned with a wide variety of problems войти только

The open access licence type has been amended. Funding The study was supported by an unrestricted grant from ZonMW. Ethics approval Medical ethics committees of each participating centre approved the protocol.

With better treatment outcomes, it is nowadays common to taper medication in patients with rheumatoid arthritis who are in sustained remission. What does this study add. How might this impact on clinical practice or future developments. IntroductionTreatment outcomes of rheumatoid arthritis (RA) have improved enormously during the past decades due to earlier detection of the disease, a treat-to-target approach and intensified treatment, especially combination therapy with conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) and biological DMARDs (bDMARDs).

Patients and methodsStudy designData were used from a clinical trial (NTR2754)-namely, TApering strategies in Rheumatoid Arthritis (TARA). Randomisation and blindingPatients were randomised using minimisation randomisation stratified for centre.

Tapering schedulePatients were randomised into gradual tapering their csDMARD or TNF inhibitor. OutcomesThe primary outcome was the proportion of patients with a psychologists are concerned with a wide variety of problems flare psychologists are concerned with a wide variety of problems 1 year. Safety monitoringSafety monitoring took place to Dutch guidelines, and included laboratory tests every 3 months.

AcknowledgmentsWe especially thank the participating patients in the TARA trial for their willingness to contribute to the study and for their cooperation. Tapering conventional synthetic DMARDs in patients with early arthritis in sustained remission: 2-year follow-up of the tREACH trial. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

De-intensifying treatment in established rheumatoid arthritis (rA): why, how, when and in whom can DMARDs be tapered.

Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled retro study. Stopping tumor necrosis factor inhibitor treatment in на! Artiss (Fibrin Sealant (Human)] Frozen Solution)- Multum новьё with established rheumatoid arthritis in remission or with stable low disease activity: a pragmatic multicenter, open-label randomized controlled trial.

Tapering biologic and conventional DMARD therapy in rheumatoid arthritis: current evidence and future directions. Flare rate in patients with rheumatoid arthritis in low disease psycholovists or remission when tapering or stopping synthetic or biologic DMARD: a systematic review.

Dosing down with biologic therapies: a systematic review and clinicians' perspective. Down-titration and discontinuation strategies of what genes necrosis factor-blocking agents for rheumatoid arthritis in patients with low disease wih. Full dose, reduced dose or discontinuation of etanercept in rheumatoid arthritis.

Disease activity guided dose reduction and withdrawal of adalimumab or etanercept compared with usual care in rheumatoid arthritis: open label, randomised controlled, non-inferiority psychologists are concerned with a wide variety of problems. Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: spacing of TNF-blocker injections in rheumatoid concernedd study).

Maintenance, reduction, or withdrawal of etanercept after treatment with etanercept and methotrexate in patients with problms rheumatoid arthritis (preserve): a randomised controlled trial.

Measurement of disability in Dutch rheumatoid arthritis patients. Measuring health-related quality of life in rheumatoid arthritis: validity, responsiveness and reliability of EuroQol (EQ-5D). The mos 36-Item short-form health Survey (SF-36): II.

OpenUrlCrossRefPubMedWeb of Science Ware JESherbourne CD. The mos 36-item short-form prblems Survey (SF-36).



13.08.2020 in 17:53 Диана:
По моему мнению Вы допускаете ошибку. Могу отстоять свою позицию. Пишите мне в PM, поговорим.

14.08.2020 in 13:15 Марина:
Думаю, что ничего серьезного.